S256: TABELECLEUCEL FOR EBV-DRIVEN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL OR SOLID ORGAN TRANSPLANT AFTER FAILURE OF RITUXIMAB ± CHEMOTHERAPY (ALLELE)
| Autor: | S. Prockop, MD, A. Beitinjaneh, MD, S. Choquet, MD, S. Dahiya, MD, R. Dinavahi, MD, R. Farah, MD, L. Gamelin, MD, PhD, A. Ghobadi, MD, A. Mehta, P. Nayak, MD, R. Reshef, MD, G. Satyanarayana, MD, P. Stiff, MD, W. Ye, PhD, K. M. Mahadeo, MD, MPH |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | HemaSphere, Vol 6, Pp 157-158 (2022) |
| Druh dokumentu: | article |
| ISSN: | 2572-9241 |
| DOI: | 10.1097/01.HS9.0000843916.04522.0a |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|
Plný text